|
Editorial Note
This week's issue includes the Technologies and Logistics Advisory Committee Briefing Report posted by Bruce Weniger, information from Omesh Bharti on a new, low-cost swine-flu detection kit developed by DRDO, and an announcement offering travel grants to participate in the Thirteenth Annual Conference on Vaccine Research. Additionally, Bernard Kaic has a question on MDVP related to the Focetria, MF59C.1 adjuvanted vaccine. |
|
 |
|
|
|
|
|
The report covers a summary presentation to the WHO Strategic Advisory Group of Experts (SAGE) on Immunization (http://www.who.int/immunization/sage/en/index.html), briefing them on the findings, conclusions, and recommendations from the September 2009 meeting of the Committee.
The topics discussed include:
• History and status of TLAC
• Out-of-the-Cold-Chain (OCC) deliberations
• Multi-Dose Vial Policy (MDVP) deliberations, and
• Other issues like VVM, vaccine freezing and auto-disabling syringes.
[Read more]
Comment on this post by email or on the web |
|
|
|
|
|
|
I have a question on multi-dose vial policy for adjuvanted pandemic vaccines.
We received Focetria, MF59C.1 adjuvanted vaccine in 10-dose presentations, which contains thimerosal as a preservative. Can the WHO multi-dose vial policy be applied to this vaccine (to use it four weeks after the first dose has been drawn from the vial)?
[Read more]
Comment on this post by email or on the web |
|
|
|
|
"The Defence Research and Development Organisation (DRDO) has developed a rapid and cost-effective swine flu virus specific isothermal gene amplification assay for reliable and early clinical diagnosis of H1N1 in human patients," ...
It is a single-tube method and cost-effective as compared to the WHO-approved Centre for Disease Control (CDC) recommended real-time Reverse Transcriptase (RT) Polymerase Chain Reaction (PCR) test system ...
[Read more]
Comment on this post by email or on the web |
|
|
|
|
Thirteen national and international agencies and organizations will collaborate with the National Foundation for Infectious Diseases in sponsoring the Thirteenth Annual Conference on Vaccine Research, April 26-28, 2010, at the Bethesda North Marriott & Conference Center Hotel, Bethesda, Maryland. The conference is the largest scientific forum devoted exclusively to the research and development of all vaccines and related technologies for prevention and treatment of disease through immunization. The conference brings together the diverse fields of human and veterinary vaccinology to encourage cross-fertilization of ideas and approaches among researchers otherwise focused on specific diseases or methods.
[Read more]
Comment on this post by email or on the web |
|
|
|
 Some of the TLAC members
Photo Courtesy: WHO
|
|
|
TechNet21 is generously supported by the Bill and Melinda Gates Foundation, under the oversight of WHO and UNICEF. The information in this forum is provided by users, as a service. All contributions are reviewed prior to posting, and all postings are attributed to the authors. The details given in emails will not be voluntarily shared or sold to any outside company and will only be used for verification and to identify postings, if necessary. The authors are solely responsible for their submissions, and the readers are solely responsible for the interpretation of these submissions. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to this forum.
For posts where the author is a WHO staff member, the author alone is reponsible for the views expressed and they do not necessarily represent the decisions, guidelines, recommendations or policies of WHO.
|
|
